S. Parikh Mars, Progressive Care CEO calls in to SmallCapVoice.com, Inc. to answer questions submitted by the Company’s shareholders. On the call she discusses the Third Quarter 2019 Financial Highlights. In addition to comprehensively covering the record-breaking financial performance metrics for the quarter ended September 30, the Company also discussed the impact of its recent FPRX acquisition, the driving forces behind the recent trend in expanding gross margins, a planned move to full SEC reporting status leading to an uplisting of shares onto a major US exchange, and its transformative vision for 2020.
Progressive Care Inc. (RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 11-14-19 for 30 days of service.